# Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data

> **NCT06229405** · — · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 8200 (estimated)

## Conditions studied

- Adrenal Tumor
- Primary Aldosteronism
- Cushing Syndrome
- Pheochromocytoma
- Adrenal Cortical Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06229405
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-05-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 8200 (ESTIMATED)
- **Last updated:** 2024-03-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06229405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06229405, "Development of Clinical Evidence for Optimal Management of Adrenal Diseases Based on Real-World Data". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06229405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*